Devonian Health Group Inc Ordinary Shares - New DHGR
Trading Information
- Previous Close Price
- $5.88
- Day Range
- $4.94–4.95
- 52-Week Range
- $0.07–10.65
- Bid/Ask
- $4.47 / $8.41
- Shares Outstanding
- 2.78M
- Market Cap
- $13.66M
- Volume/Avg
- 200 / 475
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 7.29
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development and distribution of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It has established a research effort focused on the anticipation of new solutions in the medical sector as well as in the cosmetic sector. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provides a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. Its product portfolio includes pharmaceuticals like Thykamine, Pantoprazole, and Cleo-35; and cosmeceutical products like R-Spinasome and Purgenesis.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 8
- Website
- https://www.groupedevonian.com
Valuation
|
Metric
|
DHGR
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 12.27 |
Price/Sales | 7.29 |
Price/Cash Flow | — |
Price/Earnings
DHGR
Financial Strength
|
Metric
|
DHGR
|
|---|---|
Quick Ratio | 0.78 |
Current Ratio | 1.00 |
Interest Coverage | −718.21 |
Quick Ratio
DHGR
Profitability
|
Metric
|
DHGR
|
|---|---|
Return on Assets (Normalized) | −32.13% |
Return on Equity (Normalized) | −103.52% |
Return on Invested Capital (Normalized) | −55.17% |
Return on Assets
DHGR
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|>z@D!Br | LOCK|<%pdF | $127B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|!^^$>S | LOCK|>&?#! | $76B | |||
| Moderna Inc
MRNA
| LOCK|d>n>&% | LOCK|G!P | $75B | |||
| argenx SE ADR
ARGX
| LOCK|d%?V>v | LOCK|xl | $59B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|bT?ZT&q | LOCK|&?x | $43B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|^p%r@Q | LOCK|@?&>f | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|wpHxk#V | LOCK|Np?S | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|@m>>?! | LOCK|XWr | $24B | |||
| Incyte Corp
INCY
| LOCK|HMhzNc | LOCK|Fz | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|T%pMzP | LOCK|bg | $15B |
United States